Hi-Clearance
Hi-Clearance Inc. supplies medical devices for the renal, cardiac, radiation, dental, oral surgery, and metabolism markets in Taiwan. The company offers dialyzers, dialysis and RO machines, and related consumables and drugs; interventional cardiology and radiology, and vascular surgery devices; dental consumables, implant materials, and equipment; and blood glucose monitors, and related consumabl… Read more
Hi-Clearance (1788) - Total Liabilities
Latest total liabilities as of September 2025: NT$2.03 Billion TWD
Based on the latest financial reports, Hi-Clearance (1788) has total liabilities worth NT$2.03 Billion TWD as of September 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Hi-Clearance - Total Liabilities Trend (2015–2024)
This chart illustrates how Hi-Clearance's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Hi-Clearance Competitors by Total Liabilities
The table below lists competitors of Hi-Clearance ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
AK Sigorta AS
IS:AKGRT
|
Turkey | TL22.70 Billion |
|
Pha Lai Thermal Power JSC
VN:PPC
|
Vietnam | ₫775.18 Billion |
|
Hua Eng Wire & Cable Co Ltd
TW:1608
|
Taiwan | NT$5.58 Billion |
|
SB Financial Group Inc
NASDAQ:SBFG
|
USA | $1.40 Billion |
|
Shiyan Taixiang Industry Co. Ltd. A
SHE:301192
|
China | CN¥227.39 Million |
|
Japan Cash Machine Co. Ltd
F:JCM
|
Germany | €16.09 Billion |
|
Leadtek Research Inc
TW:2465
|
Taiwan | NT$945.02 Million |
Liability Composition Analysis (2015–2024)
This chart breaks down Hi-Clearance's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.70 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.69 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.41 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Hi-Clearance's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Hi-Clearance (2015–2024)
The table below shows the annual total liabilities of Hi-Clearance from 2015 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | NT$1.96 Billion | +19.86% |
| 2023-12-31 | NT$1.63 Billion | -21.03% |
| 2022-12-31 | NT$2.07 Billion | -3.02% |
| 2021-12-31 | NT$2.13 Billion | -2.57% |
| 2020-12-31 | NT$2.19 Billion | +12.73% |
| 2019-12-31 | NT$1.94 Billion | +46.25% |
| 2018-12-31 | NT$1.33 Billion | +34.40% |
| 2017-12-31 | NT$988.28 Million | +8.25% |
| 2016-12-31 | NT$912.94 Million | +0.86% |
| 2015-12-31 | NT$905.20 Million | -- |